Pine Pharmaceuticals, LLC recalls Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded
Recalled October 25, 2023 · FDA recall D-0064-2024 · Pine Pharmaceuticals
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
860 syringes
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administration, 2 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
Manufacturer(s)
Pine Pharmaceuticals, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →